195 related articles for article (PubMed ID: 32571310)
1. Gene expression of prostaglandin EP4 receptor in three canine carcinomas.
Musser ML; Viall AK; Phillips RL; Hostetter JM; Johannes CM
BMC Vet Res; 2020 Jun; 16(1):213. PubMed ID: 32571310
[TBL] [Abstract][Full Text] [Related]
2. Prostaglandin EP4 receptor mRNA expression in canine lymphoma.
Musser ML; Viall AK; Phillips RL; Fasina O; Johannes CM
Vet Comp Oncol; 2022 Mar; 20(1):127-133. PubMed ID: 34250711
[TBL] [Abstract][Full Text] [Related]
3. Analysis of gene expression of prostaglandin EP4 receptor in canine osteosarcoma.
Musser ML; Viall AK; Phillips RL; Hostetter JM; Johannes CM
Can J Vet Res; 2021 Jan; 85(1):68-71. PubMed ID: 33390656
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of expression and function of vascular endothelial growth factor receptor 2, platelet derived growth factor receptors-alpha and -beta, KIT, and RET in canine apocrine gland anal sac adenocarcinoma and thyroid carcinoma.
Urie BK; Russell DS; Kisseberth WC; London CA
BMC Vet Res; 2012 May; 8():67. PubMed ID: 22630170
[TBL] [Abstract][Full Text] [Related]
5. Detection of human epidermal growth factor receptor 2 overexpression in canine anal sac gland carcinoma.
Yoshimoto S; Kato D; Kamoto S; Yamamoto K; Tsuboi M; Shinada M; Ikeda N; Tanaka Y; Yoshitake R; Eto S; Saeki K; Chambers JK; Kinoshita R; Uchida K; Nishimura R; Nakagawa T
J Vet Med Sci; 2019 Jul; 81(7):1034-1039. PubMed ID: 31142682
[TBL] [Abstract][Full Text] [Related]
6. The prostaglandin EP4 receptor is a master regulator of the expression of PGE
Kashmiry A; Tate R; Rotondo G; Davidson J; Rotondo D
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Oct; 1863(10):1297-1304. PubMed ID: 30053598
[TBL] [Abstract][Full Text] [Related]
7. Effects of LPA2R, LPA3R, or EP4R agonists on luteal or endometrial function in vivo or in vitro and sirtuin or EP1R, EP2R, EP3R or EP4R agonists on endometrial secretion of PGE and PGF
LaPorte ME; Weems YS; Arreguin-Arevalo A; Nett TM; Tsutahara N; Sy T; Haberman J; Chon M; Randel RD; Weems CW
Theriogenology; 2017 Jun; 95():8-17. PubMed ID: 28460684
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandin E2 promotes the cell growth and invasive ability of hepatocellular carcinoma cells by upregulating c-Myc expression via EP4 receptor and the PKA signaling pathway.
Xia S; Ma J; Bai X; Zhang H; Cheng S; Zhang M; Zhang L; Du M; Wang Y; Li H; Rong R; Shi F; Yang Q; Leng J
Oncol Rep; 2014 Oct; 32(4):1521-30. PubMed ID: 25109834
[TBL] [Abstract][Full Text] [Related]
9. Expression of cyclooxygenase-2 and EP4 receptor in transitional cell carcinoma of the upper urinary tract.
Miyata Y; Kanda S; Nomata K; Eguchi J; Kanetake H
J Urol; 2005 Jan; 173(1):56-60. PubMed ID: 15592025
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of toceranib for treatment of apocrine gland anal sac adenocarcinoma in dogs.
Heaton CM; Fernandes AFA; Jark PC; Pan X
J Vet Intern Med; 2020 Mar; 34(2):873-881. PubMed ID: 31977135
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor receptor expression in canine transitional cell carcinoma.
Hanazono K; Fukumoto S; Kawamura Y; Endo Y; Kadosawa T; Iwano H; Uchide T
J Vet Med Sci; 2015 Jan; 77(1):1-6. PubMed ID: 25223345
[TBL] [Abstract][Full Text] [Related]
12. Cell-Specific Actions of the Prostaglandin E-Prostanoid Receptor 4 Attenuating Hypertension: A Dominant Role for Kidney Epithelial Cells Compared With Macrophages.
Yang T; Song C; Ralph DL; Andrews P; Sparks MA; Koller BH; McDonough AA; Coffman TM
J Am Heart Assoc; 2022 Oct; 11(19):e026581. PubMed ID: 36172956
[TBL] [Abstract][Full Text] [Related]
13. COX-2 expression in canine anal sac adenocarcinomas and in non-neoplastic canine anal sacs.
Knudsen CS; Williams A; Brearley MJ; Demetriou JL
Vet J; 2013 Sep; 197(3):782-7. PubMed ID: 23778258
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
Wang D; Fu L; Sun H; Guo L; DuBois RN
Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
[TBL] [Abstract][Full Text] [Related]
15. Identification of survivin, an inhibitor of apoptosis, in canine urinary bladder transitional cell carcinoma.
Rankin WV; Henry CJ; Turnquist SE; Turk JR; Beissenherz ME; Tyler JW; Rucker EB; Knapp DW; Rodriguez CO; Green JA
Vet Comp Oncol; 2008 Sep; 6(3):141-50. PubMed ID: 19178674
[TBL] [Abstract][Full Text] [Related]
16. Direct growth-inhibitory effects of prostaglandin E2 in pancreatic cancer cells in vitro through an EP4/PKA-mediated mechanism.
Schmidt A; Sinnett-Smith J; Young S; Chang HH; Hines OJ; Dawson DW; Rozengurt E; Eibl G
Surgery; 2017 Jun; 161(6):1570-1578. PubMed ID: 28222855
[TBL] [Abstract][Full Text] [Related]
17. SiRNA knockdown of the DEK nuclear protein mRNA enhances apoptosis and chemosensitivity of canine transitional cell carcinoma cells.
Yamazaki H; Iwano T; Otsuka S; Kagawa Y; Hoshino Y; Hosoya K; Okumura M; Takagi S
Vet J; 2015 Apr; 204(1):60-5. PubMed ID: 25773167
[TBL] [Abstract][Full Text] [Related]
18. Pathological function of prostaglandin E2 receptors in transitional cell carcinoma of the upper urinary tract.
Miyata Y; Ohba K; Kanda S; Nomata K; Eguchi J; Hayashi T; Kanetake H
Virchows Arch; 2006 Jun; 448(6):822-9. PubMed ID: 16609907
[TBL] [Abstract][Full Text] [Related]
19. Expression of microRNAs in urinary bladder samples obtained from dogs with grossly normal bladders, inflammatory bladder disease, or transitional cell carcinoma.
Vinall RL; Kent MS; deVere White RW
Am J Vet Res; 2012 Oct; 73(10):1626-33. PubMed ID: 23013190
[TBL] [Abstract][Full Text] [Related]
20. Prostaglandin E2 concentrations in naturally occurring canine cancer.
Mohammed SI; Coffman K; Glickman NW; Hayek MG; Waters DJ; Schlittler D; DeNicola DB; Knapp DW
Prostaglandins Leukot Essent Fatty Acids; 2001 Jan; 64(1):1-4. PubMed ID: 11161579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
